Dr. Robert Kirk

• Oversaw deployment of strategic business plans to accomplish accounting, compliance and revenue targets.
• Completed in-depth analyses of risks to control company profile, enhance systems and track legal concerns.
• Set and monitored effective financial policies to analyze company financial strengths and weaknesses and propose corrective actions.
• Prepared accurate financial statements at end of quarter to summarize financial health and performance of business.
• Raised Initial Tranche of Seed Capital.

• Assisted clients with preparing financial funding strategy.
• Secured Seed Financing.
• Represented Company at Biotech Trade Shows such as J.P. Morgan conference in San Francisco.
• Secured Secondary Pre-IPO Financing.
• Introduced Company to Underwriter for 2023 IPO.
• Conducted Ophthalmic Sector Research relevan to upcoming trials and relative device effectivity versus competition for drug delivery.

.

• Led client engagements in capital sourcing, M and A and Strategic Decision Making in private and public market settings.

• Provided investors with detailed ratings based on overall earnings performance.
• Analyzed information to determine viability and rebalance portfolio.
• Developed and deepened client relationships to cement profitable partnerships.
• Evaluated investment potential of companies with thorough assessments of historical data, operational activities and future objectives.

• Completed in-depth analyses of risks to control company profile, enhance systems and track legal concerns.
• Advised CEO regarding legal dispute with former partner .
• Conducted due diligence on multiple acquisition targets.
• Secured buyer for divestiture of the entity.

• Helped leaders understand how to effectively manage preparation of financials, prepare for investor presentation, and introduced institutional capital sources.
• Gave advice on rational capital expenditure controls.
• Provided CEO, Board of Directors and lead investors with analysis of industry competitors.
• Conducted Compliance review and implemented procedures to conform with legal requirements for their automotive business.
• Represented the Company at Automotive Trade Shows.

• Located authoritative and relevant legal precedent to assess probable outcomes and potential arguments in ownership dispute litigation.
• Established relevant black letter law by researching statutes and codes to case jurisdiction.
• Prepared concise and comprehensive memoranda summarizing key findings relevant to adversaries culpability..
• Functioned as "legal detective" to buttress our case.

• Coordinated and studied financial feasability to provide recommendations for deal evaluation.
• Controlled accounting operations and oversaw transactions related to payroll, financial reporting, payables and receivables.
• Analyzed pro-forma financial statements on renewable energy projects.
• Analyzed business plans to validate and identify investment opportunities.
• Reviewed Carbon Emission Credit implications for potential projects.
• Represented Company at Industry Conferences such as ACORE.
• Traveled to Europe to conduct due diligence on projects.

• Chaired partner meetings to drive discussion of matters important to firm operations, keeping discourse on-topic and moving at efficient pace.
• Managed review of corporate and LLC-based legal transactions, coordinating document flow and logistical preparation for transactional closings.
• Conducted deal sourcing for Asian Issuers seeking US market listings.
• Coordinated Cross Border meetings and communications on various business endeavors..

• Increased company revenue from zero to 40M$ with innovative market strategies.
• Coached and guided 22 managers in 13 states to improve employee job satisfaction and achieve higher performance levels.
• Devised new promotional approaches to boost customer numbers and market penetration while enhancing engagement and driving growth; growth to 350 reps and over 20,000 customers.
• Built productive relationships with industry partners to support strategic business objectives.
• Led market making in over 300 Nasdaq securities.
• Manged Underwritings in over 30 Nasdaq IPO's.
• Represented firm as active member of RIBA Investment Banking Trade Meetings, now NIBA.